Ligand validation:3HAQ

R16: HEXADECANE

R16 is a Ligand Of Interest in 3HAQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HAQ_R16_A_411	10%	0%	0.188	0.693	4.78	9.48	15	14	0	0	100%	1
4Y9H_R16_A_309	61%	67%	0.114	0.901	0.54	0.73	-	-	0	0	100%	1
5B35_R16_A_309	34%	77%	0.197	0.879	0.42	0.51	-	-	0	0	100%	1
7VSO_R16_A_310	32%	65%	0.226	0.9	0.24	1.08	-	1	0	0	100%	1
5B34_R16_A_309	32%	76%	0.196	0.868	0.26	0.68	-	-	0	0	100%	1
3HAP_R16_A_411	31%	0%	0.142	0.811	7.28	11.83	15	14	0	0	100%	1
6GUX_R16_A_302	71%	97%	0.092	0.913	0.16	0.16	-	-	1	0	100%	1
6S6C_R16_A_302	63%	99%	0.088	0.88	0.11	0.13	-	-	2	0	100%	1
6ZO6_R16_B_1132	56%	100%	0.119	0.889	0.09	0.07	-	-	0	0	100%	1
6W8A_R16_B_410	53%	70%	0.117	0.934	0.29	0.84	-	-	0	0	69%	1
6CQ8_R16_B_411	50%	71%	0.116	0.92	0.33	0.76	-	-	0	0	69%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.